Suche

zurück zur Zentren Übersicht

Bayern

LMU Klinikum München - Medizinische Klinik und Poliklinik IV

Ziemssenstraße 5
D-80336 München

Leitung: Prof. Dr. med. Hendrik Schulze-Koops

Studien

A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacaptagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis (Breakfree-SSc)

Kontakt

Prof. Dr. med. Hendrik Schulze-Koops

Leiter der Rheumaeinheit

hendrik.schulze-koops@med.uni-muenchen.de

Studien

A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacaptagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis (Breakfree-SSc)